Quality of Life Assessment in Patients With Epilepsy Usin... | NCT07449845

Studies
Quality of Life Assessment in Patients With Epilepsy Using QOLIE-31

NCT07449845

Sponsor

Saglik Bilimleri Universitesi

Status

Completed

Last Update Posted

Apr 30, 2026Actual

Enrollment

90Actual

Phase

Not provided

Conditions

Epilepsy

Interventions

Not provided

Countries

Turkey (Türkiye)

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Feb 2026

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Feb 1, 2026Actual

Primary Completion Date

Mar 1, 2026Actual

Completion Date

Apr 1, 2026Actual

First Submitted Date

Feb 26, 2026

First Submission Date that Met QC Criteria

Feb 26, 2026

First Posted Date

Mar 4, 2026Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Apr 24, 2026

Last Update Posted Date

Apr 30, 2026Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

This observational study aims to assess quality of life in individuals with epilepsy using the Quality of Life in Epilepsy Inventory (QOLIE-31). A total of 90 adult patients with a clinical diagnosis of epilepsy will be evaluated through standardized questionnaires administered during routine clinical visits. The study seeks to characterize patient-reported quality of life across multiple domains and to provide insight into factors affecting daily functioning and well-being in people living with epilepsy.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

90Actual

Label	Type	Description	Intervention Names
epilepsy

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Quality of life measured by QOLIE-31 total score	The Quality of Life in Epilepsy Inventory-31 is a validated epilepsy-specific quality of life scale consisting of 31 items. The total score ranges from 0 to 100. Higher scores indicate better health-related quality of life.	At study enrollment

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Age ≥18 years

Clinical diagnosis of epilepsy confirmed by a neurologist

Ability to complete QOLIE-31 questionnaire

Informed consent provided

Exclusion Criteria:

Severe cognitive impairment

Acute medical or psychiatric condition interfering with participation

Inability to understand questionnaire

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Adult patients with a confirmed diagnosis of epilepsy who are receiving routine care at a neurology clinic and are able to complete the QOLIE-31 questionnaire will be included. The population reflects individuals with varying clinical characteristics encountered in everyday epilepsy practice.

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Saglik Bilimleri University Izmir Faculty of Medicine Department of Neurology		Izmir			Turkey (Türkiye)

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D004827	Epilepsy

Ancestor Terms

ID	Term
D001927	Brain Diseases
D002493	Central Nervous System Diseases
D009422	Nervous System Diseases

Browse Leaves

Not provided

Browse Branches

Not provided